NanoVibronix, Inc. (NASDAQ:NAOV – Get Free Report) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 515,200 shares, an increase of 3,311.9% from the September 30th total of 15,100 shares. Approximately 18.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 121,900 shares, the short-interest ratio is currently 4.2 days.
NanoVibronix Stock Up 5.0 %
NanoVibronix stock traded up $0.03 during midday trading on Friday, reaching $0.55. 91,001 shares of the stock traded hands, compared to its average volume of 82,782. The stock’s fifty day moving average is $0.60 and its 200-day moving average is $0.69. NanoVibronix has a 12 month low of $0.46 and a 12 month high of $1.55. The stock has a market cap of $1.52 million, a P/E ratio of -0.42 and a beta of 1.50.
NanoVibronix (NASDAQ:NAOV – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.25) earnings per share (EPS) for the quarter. NanoVibronix had a negative net margin of 83.49% and a negative return on equity of 74.98%. The company had revenue of $0.82 million for the quarter.
About NanoVibronix
NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.
Recommended Stories
- Five stocks we like better than NanoVibronix
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Texas Roadhouse Stock Steering for New Highs This Year
- What is a Bond Market Holiday? How to Invest and Trade
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Consumer Staples Stocks, Explained
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.